Cargando…
Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute
PURPOSE: To report the clinical characteristics, complications, and outcomes of hyphema in patients with sickle cell trait (SCT). DESIGN: Retrospective case series. METHODS: Medical records of SCT patients (confirmed by hemoglobin electrophoresis) presenting with hyphema at the Wilmer Eye Institute...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719005/ https://www.ncbi.nlm.nih.gov/pubmed/33293789 http://dx.doi.org/10.2147/OPTH.S281875 |
_version_ | 1783619604282605568 |
---|---|
author | Mir, Tahreem Iftikhar, Mustafa Seidel, Natalie Trang, Michelle Goldberg, Morton F Woreta, Fasika A |
author_facet | Mir, Tahreem Iftikhar, Mustafa Seidel, Natalie Trang, Michelle Goldberg, Morton F Woreta, Fasika A |
author_sort | Mir, Tahreem |
collection | PubMed |
description | PURPOSE: To report the clinical characteristics, complications, and outcomes of hyphema in patients with sickle cell trait (SCT). DESIGN: Retrospective case series. METHODS: Medical records of SCT patients (confirmed by hemoglobin electrophoresis) presenting with hyphema at the Wilmer Eye Institute over 10 years (January 2008 through December 2017) were reviewed in detail. Data were collected regarding etiology, demographics, clinical course and management. Main outcome measures included intraocular pressure (IOP) and visual acuity (VA). RESULTS: A total of 14 black patients (males: 57%; median age: 20 years) were included in the study with a median follow-up of 4 months (range: 1 week to 6 years). Ten patients had traumatic hyphema with a mean presenting VA of approximately 1.10 logMAR (Snellen equivalent=20/250) and a mean presenting IOP of 40 mmHg. Nine of them required medical intervention to lower IOP, and six of them ultimately required surgical intervention, primarily in the form of anterior chamber paracentesis and/or washout. The mean time to achieve IOP control was 3 days, and the mean final VA was approximately 0.10 logMAR (Snellen Equivalent=20/25). Four patients had non-traumatic hyphema with a mean presenting VA of approximately 1.8 logMAR (Snellen equivalent=20/1260) and a mean presenting IOP of 31 mmHg. Three of them required medical intervention to lower IOP, and two of them ultimately required surgical intervention. Overall, seven patients underwent anterior chamber washout, six needed an anterior chamber paracentesis to lower the IOP, two required tube shunt placement procedures and one patient underwent a trabeculectomy. The mean time to achieve IOP control was 5 days, and the mean final VA was approximately 0.80 logMAR (Snellen equivalent=20/125). CONCLUSION: Patients with SCT are likely to develop elevated IOP in the setting of hyphema, with a majority requiring one or more surgical interventions to achieve IOP control. |
format | Online Article Text |
id | pubmed-7719005 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-77190052020-12-07 Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute Mir, Tahreem Iftikhar, Mustafa Seidel, Natalie Trang, Michelle Goldberg, Morton F Woreta, Fasika A Clin Ophthalmol Original Research PURPOSE: To report the clinical characteristics, complications, and outcomes of hyphema in patients with sickle cell trait (SCT). DESIGN: Retrospective case series. METHODS: Medical records of SCT patients (confirmed by hemoglobin electrophoresis) presenting with hyphema at the Wilmer Eye Institute over 10 years (January 2008 through December 2017) were reviewed in detail. Data were collected regarding etiology, demographics, clinical course and management. Main outcome measures included intraocular pressure (IOP) and visual acuity (VA). RESULTS: A total of 14 black patients (males: 57%; median age: 20 years) were included in the study with a median follow-up of 4 months (range: 1 week to 6 years). Ten patients had traumatic hyphema with a mean presenting VA of approximately 1.10 logMAR (Snellen equivalent=20/250) and a mean presenting IOP of 40 mmHg. Nine of them required medical intervention to lower IOP, and six of them ultimately required surgical intervention, primarily in the form of anterior chamber paracentesis and/or washout. The mean time to achieve IOP control was 3 days, and the mean final VA was approximately 0.10 logMAR (Snellen Equivalent=20/25). Four patients had non-traumatic hyphema with a mean presenting VA of approximately 1.8 logMAR (Snellen equivalent=20/1260) and a mean presenting IOP of 31 mmHg. Three of them required medical intervention to lower IOP, and two of them ultimately required surgical intervention. Overall, seven patients underwent anterior chamber washout, six needed an anterior chamber paracentesis to lower the IOP, two required tube shunt placement procedures and one patient underwent a trabeculectomy. The mean time to achieve IOP control was 5 days, and the mean final VA was approximately 0.80 logMAR (Snellen equivalent=20/125). CONCLUSION: Patients with SCT are likely to develop elevated IOP in the setting of hyphema, with a majority requiring one or more surgical interventions to achieve IOP control. Dove 2020-12-01 /pmc/articles/PMC7719005/ /pubmed/33293789 http://dx.doi.org/10.2147/OPTH.S281875 Text en © 2020 Mir et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Mir, Tahreem Iftikhar, Mustafa Seidel, Natalie Trang, Michelle Goldberg, Morton F Woreta, Fasika A Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute |
title | Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute |
title_full | Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute |
title_fullStr | Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute |
title_full_unstemmed | Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute |
title_short | Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute |
title_sort | clinical characteristics and outcomes of hyphema in patients with sickle cell trait: 10-year experience at the wilmer eye institute |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719005/ https://www.ncbi.nlm.nih.gov/pubmed/33293789 http://dx.doi.org/10.2147/OPTH.S281875 |
work_keys_str_mv | AT mirtahreem clinicalcharacteristicsandoutcomesofhyphemainpatientswithsicklecelltrait10yearexperienceatthewilmereyeinstitute AT iftikharmustafa clinicalcharacteristicsandoutcomesofhyphemainpatientswithsicklecelltrait10yearexperienceatthewilmereyeinstitute AT seidelnatalie clinicalcharacteristicsandoutcomesofhyphemainpatientswithsicklecelltrait10yearexperienceatthewilmereyeinstitute AT trangmichelle clinicalcharacteristicsandoutcomesofhyphemainpatientswithsicklecelltrait10yearexperienceatthewilmereyeinstitute AT goldbergmortonf clinicalcharacteristicsandoutcomesofhyphemainpatientswithsicklecelltrait10yearexperienceatthewilmereyeinstitute AT woretafasikaa clinicalcharacteristicsandoutcomesofhyphemainpatientswithsicklecelltrait10yearexperienceatthewilmereyeinstitute |